<DOC>
	<DOCNO>NCT02668978</DOCNO>
	<brief_summary>The primary objective ass efficacy safety HEMOPATCHâ„¢ Sealing Hemostat reduce incidence duration air leak lung resection compare standard technique . Hypothesis : `` The routine application HEMOPATCH Sealing Hemostat visceral pleura lung resection area , lung resection procedure , EFFICIENT reduce incidence duration prolong air leak compare standard surgical measure . ''</brief_summary>
	<brief_title>SEALLS ( Sealing Evaluation Air Leaks After Lung Surgery ) Trial Using HEMOPATCH</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<criteria>Patients age 18 year able give inform consent Patients undergoing lung resection surgery either malignant benign condition include : Lobar sublobar resection Open , videoassisted thoracoscopic robotic surgery Diagnostic therapeutic procedure Traumatic pulmonary contusion laceration Lung reduction surgery Planned removal 10 lung lesion Pneumonectomy Known hypersensitivity bovine protein Known hypersensitivity Brilliant Blue FCF ( E133 ) Presence active infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>lung surgery</keyword>
	<keyword>air leak</keyword>
	<keyword>prevention</keyword>
</DOC>